中危重度症状性主动脉瓣狭窄患者行单纯介入或外科主动脉瓣置换的比较
基于德国主动脉瓣注册研究,比较2012至2014年间7613例中危(STS评分4%-8%)重度症状性主动脉瓣狭窄患者行单纯TAVR(6469例)或SAVR(1144例)的特征与结局。TAVR组年龄更大、风险评分更高;未校正住院死亡率两组均为3.6%,未校正1年死亡率TAVR较高(17.5% vs 10.8%),但倾向评分匹配后1年死亡率差异无统计学意义(17.1% vs 15.7%)。
要点
- 中危患者中TAVR与SAVR的住院死亡率均为3.6%。
- 倾向评分匹配后两组1年死亡率差异无统计学意义。
- 选择TAVR的患者年龄更大且基线风险评分更高。
核心结论
- 中危患者行单纯TAVR与SAVR的住院死亡率均为3.6%,倾向评分匹配后1年死亡率无显著差异。
研究设计与样本
- 前瞻性全comers德国主动脉瓣注册研究,纳入2012至2014年间92个中心的7613例中危(STS评分4%-8%)行单纯TAVR(n=6469)或SAVR(n=1144)的患者。
主要发现
- TAVR组年龄显著大于SAVR组(82.5±5.0 vs 76.6±6.7岁,P<0.001)。
- TAVR组logistic EuroSCORE(21.2±12.3% vs 14.2±9.5%,P<0.001)和STS评分(5.6±1.1 vs 5.2±1.0,P<0.001)均更高。
- 未校正住院死亡率两组均为3.6%(P=0.976)。
- 未校正1年死亡率TAVR组显著高于SAVR组(17.5% vs 10.8%,P<0.001)。
- 倾向评分匹配后1年死亡率差异无统计学意义(17.1% vs 15.7%,P=0.59)。
关键数值与推荐
- 中危定义为Society of Thoracic Surgeons评分4%-8%。
- 多变量分析显示高龄、冠心病、NYHA III/IV级、肺动脉高压、既往心脏失代偿、择期手术、动脉闭塞性疾病、无糖尿病及较小主动脉瓣面积与选择TAVR而非SAVR相关(均P<0.001)。
临床怎么用
- 中危主动脉瓣狭窄患者选择TAVR或SAVR需综合评估年龄与基线特征。
- 倾向评分匹配后两者1年死亡率相当,支持个体化决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transcatheter aortic valve replacement (TAVR) is increasingly being used for treatment of severe aortic valve stenosis in patients at intermediate risk for surgical aortic valve replacement (SAVR). Currently, real-world data comparing indications and clinical outcomes of patients at intermediate surgical risk undergoing isolated TAVR with those undergoing SAVR are scarce. METHODS: We compared clinical characteristics and outcomes of patients with intermediate surgical risk (Society of Thoracic Surgeons score 4%-8%) who underwent isolated TAVR or conventional SAVR within the prospective, all-comers German Aortic Valve Registry. RESULTS: A total of 7613 patients at intermediate surgical risk underwent isolated TAVR (n=6469) or SAVR (n=1144) at 92 sites in Germany between 2012 and 2014. Patients treated by TAVR were significantly older (82.5±5.0 versus 76.6±6.7 years, P<0.001) and had higher risk scores (logistic EuroSCORE [European System for Cardiac Operative Risk Evaluation]: 21.2±12.3% versus 14.2±9.5%, P<0.001; Society of Thoracic Surgeons score: 5.6±1.1 versus 5.2±1.0, P<0.001). Multivariable analyses revealed that advanced age, coronary artery disease, New York Heart Association class III/IV, pulmonary hypertension, prior cardiac decompensation, elective procedure, arterial occlusive disease, no diabetes mellitus, and a smaller aortic valve area were associated with performing TAVR instead of SAVR (all P<0.001). Unadjusted in-hospital mortality rates were equal for TAVR and SAVR (3.6% versus 3.6%, P=0.976), whereas unadjusted 1-year mortality was significantly higher in patients after TAVR (17.5% versus 10.8%, P<0.001). After propensity score matching, the difference in 1-year mortality between patients with TAVR and SAVR was no longer significant (17.1% versus 15.7%, P=0.59). CONCLUSIONS: Patients at intermediate risk undergoing TAVR differ significantly from those treated with SAVR with regard to age and baseline characteristics. Isolated TAVR and SAVR were associated with an in-hospital mortality rate of 3.6%. In the propensity score analysis, there was no significant difference in 1-year mortality between patients with TAVR and SAVR.
引用
- Werner N, Zahn R, Beckmann A, et al. Patients at Intermediate Surgical Risk Undergoing Isolated Interventional or Surgical Aortic Valve Implantation for Severe Symptomatic Aortic Valve Stenosis. Circulation. 2018. PMID: 30571255. doi:10.1161/CIRCULATIONAHA.117.033048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。